Exicure, Inc. (XCUR)

0.6084 +0.0129 (+2.17%) At close: 04:00PM EDT

Exicure, Inc.

2430 North Halsted Street
Chicago, IL 60614
United States
847 673 1700
https://www.exicuretx.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 7

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Paul Kang	CEO & Director	N/A	N/A	1962
Ms. Jiyoung Hwang	CFO & Director	N/A	N/A	1977
Mr. Joshua Miller	Chief Accounting Officer	N/A	N/A	1976
Mr. Bart Anderson	Senior Director of R&D	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Exicure, Inc., an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

Corporate governance

Exicure, Inc.’s ISS governance QualityScore as of 1 April 2024 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder rights: 7; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.